Histone Deacetylase 4: The Epigenetic Hub In Degenerative Musculoskeletal Diseases
Our bodies are complex, and sometimes the way our genes are turned on or off can lead to health problems, even without changes to the DNA itself. This process is called epigenetics. A recent review highlights the critical role of an enzyme called Histone Deacetylase 4, or HDAC4, in a group of conditions known as degenerative musculoskeletal diseases (DMDs). These diseases, which include common ailments like osteoarthritis and osteoporosis, involve the breakdown of our bones, cartilage, and muscles, and are a growing concern, especially as we age.
HDAC4 acts like a central control point, influencing how cells in our cartilage, bones, and muscles function. It plays a part in maintaining healthy cartilage cells (chondrocyte homeostasis), managing inflammation in our joints (synovial inflammation), balancing bone formation and breakdown (osteoblast-osteoclast balance), and even preventing muscle wasting (muscle fiber atrophy). When this enzyme doesn’t function correctly, it contributes to the progression of DMDs.
Understanding HDAC4’s role opens up exciting possibilities for new treatments. By specifically targeting this enzyme, scientists hope to develop therapies that could help prevent or slow down the damage seen in conditions like osteoarthritis, osteoporosis, and muscle atrophy, ultimately improving the lives of many.
Source: link to paper